{
  "id": 157093,
  "title": "Gilead’s Yeztugo beats forecasts as HIV PrEP franchise exceeds $1B",
  "url": "https://urgent.news/2026/08/05/gileads-yeztugo-beats-forecasts-as-hiv-prep-franchise-exceeds-1b",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-05T01:21:22.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/gileads-yeztugo-beats-forecasts-as-hiv-prep-franchise-exceeds-1b/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Gilead said its twice-yearly HIV prevention shot Yeztugo generated $232 million in sales in the second quarter, topping Wall Street estimates of $221 million. The beat comes about three months after Gilead said it expected ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}